SD HEALTHCARE

Roche Buys S.D. Drugmaker Ignyta for $1.7B

The pharma giant is betting on Ignyta's cancer drug, entrectinib, which is intended to treat patients with rare cancers.

Tease photo

Ionis and Biogen Expand Partnership

Carlsbad’s Ionis Pharmaceuticals and Biogen have expanded their collaboration to identify new drug candidates for the treatment of spinal muscular atrophy (SMA).

New Owner Brings New Strategy for Proton Therapy Center

MEDICINE: It Will Seek Closer Ties With UCSD Health, Bolster Marketing

The region’s first and only proton therapy center has relaunched under new ownership and management after a chapter 11 bankruptcy filing protection last spring.

Tease photo

Sirenas LLC Lands Second Bill & Melinda Gates Foundation Grant

The marine-centric biotech, which has now secured $1.68 million, will use the money to discover potential therapies to treat infectious diseases.

Palomar Health Reaches Tentative Deals with Nurses, Caregivers

The agreements, which cover more than 3,000 employees who are seven months into working without a contract, must still be ratified.

Genoptix to Buy Rosetta Genomics for $10M

The deal, expected to close during the first quarter of 2018, was unanimously approved by both companies’ boards.

Renova Therapeutics’ Drug Receives FDA Fast Track Status

The lead product candidate is a gene transfer drug to treat heart disease.

Becoming Part of The (Health) Plan

Wellness Cos. Help Care and Coverage Providers Find Ways to Effectively Reach and Influence Diverse Customer Bases

Swaying rural teens in Arkansas to stay away from chewing tobacco, a habit ingrained in the local culture, is no easy task. Nor is crafting relatable messages for teens on the dangers of prescription painkiller abuse.

Tease photo

Halozyme Licensing Deal Could Be Worth Much More Than $40M

San Diego’s Halozyme Therapeutics will receive a $40 million upfront payment, and potentially much more, as part of a collaboration and licensing deal with Alexion Pharmaceuticals.

Metacrine Gets $22M in Funding Round, New Board Member

San Diego biotech Metacrine, which is working on drugs for liver and metabolic diseases, has closed a $22 million Series B financing round.

Proton Therapy Center Relaunches with New Ownership

California Protons is one of only two proton therapy centers in California and 25 nationwide.

NanoCellect Raises $10M in Funding Round

San Diego biotech raised $10 million in a Series B round, led by investment from Illumina Ventures.

Tease photo

Rancho Bernardo Exercise Studio to Combine Yoga and Float Therapy

Yauvana Yoga & Float is set to open in January.

Human Longevity CEO Makes Quick Exit; Venter Back in Top Spot

Human Longevity Inc. CEO Cynthia Collins is out after less than a year in the top spot at the San Diego-based genomics company.

CRO Navigates Tough Preclinical Testing Stage for Cos.

BIOTECH: Challenges Are Big And Small in Testing on Animals

Explora Biolabs is part of San Diego’s biotech cluster. But CEO Richard Lin likens the company to a hotel.

Tease photo